These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 36649969)

  • 1. Better recognition for research participants: what society should learn from covid-19.
    Kraft SA; Rohrig A; Williams A; Shah SK
    BMJ; 2023 Jan; 380():e071178. PubMed ID: 36649969
    [No Abstract]   [Full Text] [Related]  

  • 2. Mental illness in society as we learn to live with COVID-19.
    Donnelly SC
    QJM; 2022 Sep; 115(9):573. PubMed ID: 36135354
    [No Abstract]   [Full Text] [Related]  

  • 3. Socio-demographic Heterogeneity in Prevalence of SARS-COV-2 Infection and Death Rate: Relevance to Black College Student Knowledge of COVID-19 and SARS-COV-2.
    Emrani J; Hefner EN
    J Racial Ethn Health Disparities; 2023 Feb; 10(1):14-31. PubMed ID: 35119679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Cholera Epidemics in Hamburg and What to Learn for COVID-19 (SARS-CoV-2).
    Tárnok A
    Cytometry A; 2020 Apr; 97(4):337-339. PubMed ID: 32187818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comprehensive SARS-CoV-2 and COVID-19 review, Part 2: host extracellular to systemic effects of SARS-CoV-2 infection.
    Narayanan SA; Jamison DA; Guarnieri JW; Zaksas V; Topper M; Koutnik AP; Park J; Clark KB; Enguita FJ; Leitão AL; Das S; Moraes-Vieira PM; Galeano D; Mason CE; Trovão NS; Schwartz RE; Schisler JC; Coelho-Dos-Reis JGA; Wurtele ES; Beheshti A
    Eur J Hum Genet; 2024 Jan; 32(1):10-20. PubMed ID: 37938797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long COVID symptoms in SARS-CoV-2-positive adolescents and matched controls (LongCOVIDKidsDK): a national, cross-sectional study.
    Kikkenborg Berg S; Dam Nielsen S; Nygaard U; Bundgaard H; Palm P; Rotvig C; Vinggaard Christensen A
    Lancet Child Adolesc Health; 2022 Apr; 6(4):240-248. PubMed ID: 35143771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What did we learn from the previous coronavirus epidemics and what can we do better: a neuroinfectiological point of view.
    Akhvlediani T; Jelcic I; Taba P; Pfausler B; Steiner I; Sellner J
    Eur J Neurol; 2020 Nov; 27(11):e69-e72. PubMed ID: 32526060
    [No Abstract]   [Full Text] [Related]  

  • 8. What can we learn from brain autopsies in COVID-19?
    Mukerji SS; Solomon IH
    Neurosci Lett; 2021 Jan; 742():135528. PubMed ID: 33248159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Level up for culture models - How 3D cell culture models benefit SARS-CoV-2 research.
    Häfner SJ
    Biomed J; 2021 Mar; 44(1):1-6. PubMed ID: 33741318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The most common skin symptoms in young adults and adults related to SARS-CoV-2 virus infection.
    Zaborska M; Chruszcz M; Sadowski J; Klaudel T; Pelczarski M; Sztangreciak-Lehun A; Bułdak RJ
    Arch Dermatol Res; 2024 May; 316(6):292. PubMed ID: 38819524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early Recognition of Low-Risk SARS-CoV-2 Pneumonia: A Model Validated With Initial Data and Infectious Diseases Society of America/American Thoracic Society Minor Criteria.
    Menéndez R; Méndez R; González-Jiménez P; Zalacain R; Ruiz LA; Serrano L; España PP; Uranga A; Cillóniz C; Pérez-de-Llano L; Golpe R; Torres A
    Chest; 2022 Oct; 162(4):768-781. PubMed ID: 35609674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Daily use of lateral flow devices by contacts of confirmed COVID-19 cases to enable exemption from isolation compared with standard self-isolation to reduce onward transmission of SARS-CoV-2 in England: a randomised, controlled, non-inferiority trial.
    Love NK; Ready DR; Turner C; Verlander NQ; French CE; Martin AF; Sorensen TB; Metelmann S; Denford S; Rubin GJ; Yardley L; Amlôt R; Hopkins S; Oliver I
    Lancet Respir Med; 2022 Nov; 10(11):1074-1085. PubMed ID: 36228640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2: An Insight into Detection Tools.
    Khanmohammadi S; Tabary M; Araghi F; Tavangar SM
    Infect Disord Drug Targets; 2021; 21(8):e160921189885. PubMed ID: 33397246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A longitudinal SARS-CoV-2 biorepository for COVID-19 survivors with and without post-acute sequelae.
    LaVergne SM; Stromberg S; Baxter BA; Webb TL; Dutt TS; Berry K; Tipton M; Haberman J; Massey BR; McFann K; Alnachoukati O; Zier L; Heacock T; Ebel GD; Henao-Tamayo M; Dunn J; Ryan EP
    BMC Infect Dis; 2021 Jul; 21(1):677. PubMed ID: 34256735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An ongoing science-society-ethics experiment: The human challenge trial debate in COVID-19 pandemic: The human challenge trial debate in COVID-19 pandemic.
    Vasconcelos SMR; Esher A; Penido C; Lima C; Rocha KA; Antunes MJM; Ribeiro MD; Pedrotti M
    EMBO Rep; 2022 Jan; 23(1):e54184. PubMed ID: 34897954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbiology Society online workshop on SARS-CoV-2 and COVID-19, Wednesday 29 July 2020.
    Harris M
    J Gen Virol; 2020 Dec; 101(12):1227-1228. PubMed ID: 32996880
    [No Abstract]   [Full Text] [Related]  

  • 17. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 in the knee joint: a cadaver study.
    Grassi M; Giorgi V; Nebuloni M; Zerbi P; Gismondo MR; Salaffi F; Sarzi-Puttini P; Rimoldi SG; Manzotti A
    Clin Exp Rheumatol; 2022 Mar; 40(3):608-612. PubMed ID: 34665699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.
    Baden LR; El Sahly HM; Essink B; Kotloff K; Frey S; Novak R; Diemert D; Spector SA; Rouphael N; Creech CB; McGettigan J; Khetan S; Segall N; Solis J; Brosz A; Fierro C; Schwartz H; Neuzil K; Corey L; Gilbert P; Janes H; Follmann D; Marovich M; Mascola J; Polakowski L; Ledgerwood J; Graham BS; Bennett H; Pajon R; Knightly C; Leav B; Deng W; Zhou H; Han S; Ivarsson M; Miller J; Zaks T;
    N Engl J Med; 2021 Feb; 384(5):403-416. PubMed ID: 33378609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Care of the Seriously Ill Patient with SARS-CoV-2.
    Leither LM; Buckel W; Brown SM
    Med Clin North Am; 2022 Nov; 106(6):949-960. PubMed ID: 36280338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.